Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Talanta|December 6, 2014
Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapyMarina Venzon Antunes, Suziane Raymundo, Vanessa de Oliveira, et al.Journal of Pharmaceutical and Biomedical Analysis|December 8, 2017
Determination of irinotecan and its metabolite SN-38 in dried blood spots using high-performance liquid-chromatography with fluorescence detectionRoberta Z Hahn, Priscila C Arnhold, Natália B Andriguetti, et al.Current Neurovascular Research|May 14, 2008
Gastrin-releasing peptide receptors regulate proliferation of C6 Glioma cells through a phosphatidylinositol 3-kinase-dependent mechanismDebora Gazzana Flores, Caroline Brunetto de Farias, Juliano Leites, et al.Oncology|April 9, 2011
BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancerCaroline Brunetto de Farias, Denis Broock Rosemberg, Tiago Elias Heinen, et al.Diabetes, Obesity & Metabolism|February 23, 2024
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysisLeonardo A Mesquita, Bernardo F Spiazzi, Giovana F Piccoli, et al.American Journal of Respiratory and Critical Care Medicine|September 30, 2005
Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsisFelipe Dal-Pizzol, Luciane Pons Di Leone, Cristiane Ritter, et al.Lancet (London, England)|November 30, 2015
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trialAndrea Wang-Gillam, Chung-Pin Li, György Bodoky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate CancerCora Sternberg, Andrew Armstrong, Roberto Pili, et al.European Journal of Cancer (Oxford, England : 1990)|November 11, 2018
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trialLi-Tzong Chen, Jens T Siveke, Andrea Wang-Gillam, et al.Molecular Medicine (Cambridge, Mass.)|June 28, 2012
Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signalingFabricia Petronilho, Francieli Vuolo, Letícia Selinger Galant, et al.Pageof 15